In vitro and in vivo Evaluation of Succinic Acid-Substituted Mesoporous Silica for Ammonia Adsorption: Potential Application in the Management of Hepatic Encephalopathy

References

• Bhushan B. Springer Handbook of Nanotechnology. Springer; 2017:1–19.
   Google Scholar
• Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine. 2019;14(1):93–126. doi:10.2217/nnm-2018-0120.30451076
   PubMed Web of Science ®Google Scholar
• Farjadian F, Moghoofei M, Mirkiani S, et al. Bacterial components as naturally inspired nano-carriers for drug/gene delivery and immunization: set the bugs to work? Biotechnol Adv. 2018;36(4):968–985. doi:10.1016/j.biotechadv.2018.02.016.29499341
   PubMed Web of Science ®Google Scholar
• Karimi M, Ghasemi A, Mirkiani S, Basri MM, Hamblin M. Carbon Nanotubes in Drug and Gene Delivery. Morgan & Claypool Publishers; 2017.
   Google Scholar
• Farjadian F, Roointan A, Mohammadi-Samani S, Hosseini M. Mesoporous silica nanoparticles: synthesis, pharmaceutical applications, biodistribution, and biosafety assessment. Chem Eng J. 2019;359:684–705. doi:10.1016/j.cej.2018.11.156.
   Web of Science ®Google Scholar
• Bernardos Bau A, Kourimska L. Applications of mesoporous silica materials in food: a review. Czech J Food Sci. 2013;31(2):99–107. doi:10.17221/240/2012-CJFS.
   Web of Science ®Google Scholar
• Ouyang G, Yang G, Sun C, Zhu W. Nanoporous structures: smaller is stronger. Small. 2008;4(9):1359–1362. doi:10.1002/smll.200800129.18690640
   PubMed Web of Science ®Google Scholar
• Kresge C, Leonowicz M, Roth WJ, Vartuli J, Beck J. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. nature. 1992;359(6397):710–712. doi:10.1038/359710a0.
   Web of Science ®Google Scholar
• Akbarian M, Tayebi L, Mohammadi-Samani S, Farjadian F. Mechanistic assessment of functionalized mesoporous silica-mediated insulin fibrillation. J Phys Chem B. 2020;124(9):1637–1652. doi:10.1021/acs.jpcb.9b10980.32045248
   PubMed Web of Science ®Google Scholar
• Ghorbani M, Nowee SM. Kinetic studies of Pb and Ni adsorption onto MCM-41 amine-functionalized nano particle. Adv Environ Technol. 2015;1(2):101–104. doi:10.22104/aet.2015.269.
   Google Scholar
• Soltani R, Dinari M, Mohammadnezhad G. Ultrasonic-assisted synthesis of novel nanocomposite of poly (vinyl alcohol) and amino-modified MCM-41: a green adsorbent for Cd (II) removal. Ultrason Sonochem. 2018;40:533–542. doi:10.1016/j.ultsonch.2017.07.045.28946455
   PubMed Web of Science ®Google Scholar
• Melde BJ, Johnson BJ, Charles PT. Mesoporous silicate materials in sensing. Sensors. 2008;8(8):5202–5228. doi:10.3390/s8085202.27873810
   PubMed Web of Science ®Google Scholar
• Farjadian F, Hosseini M, Ghasemi S, Tamami B. Phosphinite-functionalized silica and hexagonal mesoporous silica containing palladium nanoparticles in Heck coupling reaction: synthesis, characterization, and catalytic activity. RSC Adv. 2015;5(97):79976–79987. doi:10.1039/C5RA16131B.
   Web of Science ®Google Scholar
• Popova M, Szegedi A, Yoncheva K, et al. New method for preparation of delivery systems of poorly soluble drugs on the basis of functionalized mesoporous MCM-41 nanoparticles. Micropor Mesopor Mater. 2014;198:247–255. doi:10.1016/j.micromeso.2014.07.044.
   Web of Science ®Google Scholar
• Nhavene EPF, Andrade GF, Faria JAQA, Gomes DA, Sousa E. Biodegradable polymers grafted onto multifunctional mesoporous silica nanoparticles for gene delivery. ChemEngineering. 2018;2(2):24. doi:10.3390/chemengineering2020024.
   Google Scholar
• Dimos K, Stathi P, Karakassides MA, Deligiannakis Y. Synthesis and characterization of hybrid MCM-41 materials for heavy metal adsorption. Micropor Mesopor Mater. 2009;126(1–2):65–71. doi:10.1016/j.micromeso.2009.05.021.
   Web of Science ®Google Scholar
• Dinh Du D, Hieu NT, To TC, et al. Aminopropyl functionalised MCM-41: synthesis and application for adsorption of Pb (II) and Cd (II). Adv Mater Sci Eng. 2019:2019. doi:10.1155/2019/8573451.
   Web of Science ®Google Scholar
• Farjadian F, Ghasemi S, Heidari R, Mohammadi-Samani S. In vitro and in vivo assessment of EDTA-modified silica nano-spheres with supreme capacity of iron capture as a novel antidote agent. Nanomed Nanotechnol Biol Med. 2017;13(2):745–753. doi:10.1016/j.nano.2016.10.012.
   PubMed Web of Science ®Google Scholar
• Taqanaki ER, Heidari R, Monfared M, Tayebi L, Azadi A, Farjadian F. EDTA-modified mesoporous silica as supra adsorbent of copper ions with novel approach as an antidote agent in copper toxicity. Int J Nanomedicine. 2019;14:7781–7792. doi:10.2147/IJN.S218760.31576122
   PubMed Web of Science ®Google Scholar
• Bhatia V, Singh R, Acharya SK. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut. 2006;55(1):98–104. doi:10.1136/gut.2004.061754.16024550
   PubMed Web of Science ®Google Scholar
• Romero-Gómez M. Pharmacotherapy of hepatic encephalopathy in cirrhosis. Expert Opin Pharmacother. 2010;11(8):1317–1327. doi:10.1517/14656561003724721.20384539
   PubMed Web of Science ®Google Scholar
• Prakash R, Mullen KD. Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol. 2010;7(9):515. doi:10.1038/nrgastro.2010.116.20703237
   PubMed Web of Science ®Google Scholar
• Shawcross D, Wright G, Damink SO, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22(1):125–138. doi:10.1007/s11011-006-9042-1.17260161
   PubMed Web of Science ®Google Scholar
• Rodrigo R, Cauli O, Gomez–Pinedo U, et al. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology. 2010;139(2):675–684. doi:10.1053/j.gastro.2010.03.040.20303348
   PubMed Web of Science ®Google Scholar
• Leevy CB, Phillips JA. Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Dig Dis Sci. 2007;52(3):737–741. doi:10.1007/s10620-006-9442-4.17245628
   PubMed Web of Science ®Google Scholar
• Greenberger NJ, Carley J, Schenker S, Bettinger I, Stamnes C, Beyer P. Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Am J Dig Dis. 1977;22(10):845–855. doi:10.1007/BF01076158.335882
   PubMedGoogle Scholar
• Riggio O, Ariosto F, Merli M, et al. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Dig Dis Sci. 1991;36(9):1204–1208. doi:10.1007/BF01307509.1893805
   PubMed Web of Science ®Google Scholar
• Stauch S, Kircheis G, Adler G, et al. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. J Hepatol. 1998;28(5):856–864. doi:10.1016/s0168-8278(98)80237-7.9625322
   PubMed Web of Science ®Google Scholar
• Naylor CD, O’Rourke K, Detsky AS, Baker JP. Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: a meta-analysis. Gastroenterology. 1989;97(4):1033–1042. doi:10.1016/0016-5085(89)91517-5.2506095
   PubMed Web of Science ®Google Scholar
• Bosoi CR, Parent‐Robitaille C, Anderson K, Tremblay M, Rose CF. AST‐120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct–ligated rats. Hepatology. 2011;53(6):1995–2002. doi:10.1002/hep.24273.21384402
   PubMed Web of Science ®Google Scholar
• Solorzano L. Determination of ammonia in natural waters by the phenolhypochlorite method Limnology and oceanography. Limnol Oceanogr. 1969;14(5):799–801. doi:10.4319/lo.1969.14.5.0799.
   Web of Science ®Google Scholar
• Bolleter W, Bushman C, Tidwell PW. Spectrophotometric determination of ammonia as indophenol. Anal Chem. 1961;33(4):592–594. doi:10.1021/ac60172a034.
   Web of Science ®Google Scholar
• Farjadian F, Rezaeifard S, Naeimi M, et al. Temperature and pH-responsive nano-hydrogel drug delivery system based on lysine-modified poly (vinylcaprolactam). Int J Nanomedicine. 2019;14:6901–6915. doi:10.2147/IJN.S214467.31564860
   PubMed Web of Science ®Google Scholar
• Tuñón MJ, Alvarez M, Culebras JM, González-Gallego J. An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol. 2009;15(25):3086. doi:10.3748/wjg.15.3086.19575487
   PubMed Web of Science ®Google Scholar
• Jamshidzadeh A, Abdoli N, Niknahad H, et al. Taurine alleviates brain tissue markers of oxidative stress in a rat model of hepatic encephalopathy. Trends Pharma Sci. 2017;3(3):181–192.
   Google Scholar
• Ali S, Ansari KA, Jafry M, Kabeer H, Diwakar G. Nardostachys jatamansi protects against liver damage induced by thioacetamide in rats. J Ethnopharmacol. 2000;71(3):359–363. doi:10.1016/S0378-8741(99)00153-1.10940571
   PubMed Web of Science ®Google Scholar
• Ommati MM, Farshad O, Mousavi K, Khalili M, Jamshidzadeh A, Heidari R. Chlorogenic acid supplementation improves skeletal muscle mitochondrial function in a rat model of resistance training. Biologia. 2020;75(8):1221–1230. doi:10.2478/s11756-020-00429-7.
   Web of Science ®Google Scholar
• Carter RJ, Morton J, Dunnett SB. Motor coordination and balance in rodents. Curr Protocols Neurosci. 2001;15(1):8.12. 11–18.12. 14. doi:10.1002/0471142301.ns0812s15.
   Google Scholar
• Metz GA, Merkler D, Dietz V, Schwab ME, Fouad K. Efficient testing of motor function in spinal cord injured rats. Brain Res. 2000;883(2):165–177. doi:10.1016/s0006-8993(00)02778-5.11074045
   PubMed Web of Science ®Google Scholar
• Ommati MM, Heidari R, Ghanbarinejad V, Abdoli N, Niknahad H. Taurine treatment provides neuroprotection in a mouse model of manganism. Biol Trace Elem Res. 2019;190(2):384–395. doi:10.1007/s12011-018-1552-2.30357569
   PubMed Web of Science ®Google Scholar
• Heidari R, Jafari F, Khodaei F, Shirazi Yeganeh B, Niknahad H. Mechanism of valproic acid‐induced Fanconi syndrome involves mitochondrial dysfunction and oxidative stress in rat kidney. Nephrology. 2018;23(4):351–361. doi:10.1111/nep.13012.28141910
   PubMed Web of Science ®Google Scholar
• Ommati MM, Heidari R, Ghanbarinejad V, Aminian A, Abdoli N, Niknahad H. The neuroprotective properties of carnosine in a mouse model of manganism is mediated via mitochondria regulating and antioxidative mechanisms. Nutr Neurosci. 2020;23(9):731–743. doi:10.1080/1028415X.2018.1552399.30856059
   PubMed Web of Science ®Google Scholar
• Heidari R, Jamshidzadeh A, Niknahad H, et al. Effect of taurine on chronic and acute liver injury: focus on blood and brain ammonia. Toxicol Rep. 2016;3:870–879. doi:10.1016/j.toxrep.2016.04.002.28959615
   PubMed Web of Science ®Google Scholar
• Ommati MM, Jamshidzadeh A, Niknahad H, et al. N-acetylcysteine treatment blunts liver failure-associated impairment of locomotor activity. Pharm Nutr. 2017;5(4):141–147. doi:10.1016/j.phanu.2017.10.003.
   Google Scholar
• Heidari R, Behnamrad S, Khodami Z, Ommati MM, Azarpira N, Vazin A. The nephroprotective properties of taurine in colistin-treated mice is mediated through the regulation of mitochondrial function and mitigation of oxidative stress. Biomed Pharmacother. 2019;109:103–111. doi:10.1016/j.biopha.2018.10.093.30396066
   PubMed Web of Science ®Google Scholar
• Heidari R. Brain mitochondria as potential therapeutic targets for managing hepatic encephalopathy. Life Sci. 2019;218:65–80. doi:10.1016/j.lfs.2018.12.030.30578865
   PubMed Web of Science ®Google Scholar
• Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis. 2002;17(4):221–227. doi:10.1023/a:1021989230535.12602499
   PubMed Web of Science ®Google Scholar
• Heidari R, Niknahad H. The role and study of mitochondrial impairment and oxidative stress in cholestasis In: Vinken M, editor. Experimental Cholestasis Research. New York: Springer New York; 2019:117–132.
   Google Scholar
• Hadjihambi A, Jalan R. Hepatic encephalopathy: new treatments. Clin Liver Dis. 2015;5(5):109. doi:10.1002/cld.468.
   Google Scholar
• Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit. 2011;17(2):RA53. doi:10.12659/msm.881387.21278704
   PubMed Web of Science ®Google Scholar
• Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv Mater. 2012;24(12):1504–1534. doi:10.1002/adma.201104763.22378538
   PubMed Web of Science ®Google Scholar
• Farjadian F, Azadi S, Mohammadi-Samani S, Ashrafi H, Azadi A. A novel approach to the application of hexagonal mesoporous silica in solid-phase extraction of drugs. Heliyon. 2018;4(11):e00930. doi:10.1016/j.heliyon.2018.e00930.30456326
   PubMed Web of Science ®Google Scholar